Skip to main content

What the FDA labels say about taking them together

Colchicine and ensitrelvir

Ensitrelvir's FDA label of June 3, 2026 names colchicine in its drug interactions section; the colchicine labels PlainMeds reads (4) do not name ensitrelvir. The ensitrelvir label: “Co-administration is contraindicated due to potential for serious and/or life-threatening reactions in patients with renal and/or hepatic impairment.”

Check it at the source: the colchicine FDA label on DailyMed (effective July 22, 2025, Aurobindo Pharma Limited); the ensitrelvir FDA label on DailyMed (effective June 3, 2026, Shionogi Inc.).

What does the colchicine label say about ensitrelvir?

Colchicine's label (effective July 22, 2025) and its 3 other brand-application labels do not name ensitrelvir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Colchicine), Aurobindo Pharma Limited, effective July 22, 2025 (SPL set dd93a40f-92ab-47ac-9083-b8a7a0b18ad6), via openFDA; the full label on DailyMed

What does the ensitrelvir label say about colchicine?

Ensitrelvir label, drug interactions

Drug Class: Antigout agents; Drug (s) within Class: colchicine; Effect on Drug Concentration: ↑ colchicine; Clinical Comment: Co-administration is contraindicated due to potential for serious and/or life-threatening reactions in patients with renal and/or hepatic impairment.

Source: FDA drug label (XOCOVA), Shionogi Inc., effective June 3, 2026 (SPL set 526acf60-abc3-2cc2-e063-6294a90affa6), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

30Colchicine generic labelers
0Ensitrelvir generic labelers
ColchicineEnsitrelvir
Labeled forGoutCOVID-19
Boxed warningNoNo
Pharmacy cost (NADAC)$0.122 per tablet 0.6 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?